文献速递甲状腺疾病

儿童分化型甲状腺癌的疾病特征与侵袭性预测因素:CATC研究

The landscape of pediatric differentiated thyroid carcinoma and predictors of invasive disease: a CATC study.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

该国际多中心回顾性研究分析了2010至2019年5家中心诊断的715例儿童分化型甲状腺癌患者,中位年龄15.2岁,78.3%为女性。研究发现侵袭性疾病与年龄小于10岁、男性、致癌性融合基因驱动及甲状腺外侵犯相关;2015年后治疗强度降低未导致疾病结局恶化。

要点

  • 儿童DTC中侵袭性疾病与年龄<10岁、男性、致癌性融合基因及甲状腺外侵犯相关。
  • 2015年后治疗强度降低未伴随疾病结局恶化。
  • 男性及年龄<10岁儿童表现出更晚的T、N、M分期。

核心结论

  • 侵袭性儿童DTC与年龄<10岁、男性、致癌性融合基因驱动及甲状腺外侵犯相关。
  • 近年来治疗强度降低后疾病结局未恶化。

研究设计与样本

  • 国际多中心回顾性分析,纳入2010至2019年诊断的年龄<19岁儿童DTC患者。
  • 来自5家高容量儿科中心,共715例儿童。

主要发现

  • 队列中78.3%为女性,中位诊断年龄15.2岁(范围3.2-18.9岁)。
  • 673例(94%)为甲状腺乳头状癌,42例(6%)为滤泡状甲状腺癌。
  • 乳头状癌中83.5%(562例)为1期(M0),16.5%(111例)为2期(M1);滤泡状癌中1/42(2.4%)为M1。
  • 男性及年龄<10岁儿童表现出更晚的T、N、M分期。
  • 致癌性融合基因相比BRAFV600E与更晚的N和M分期相关。

临床怎么用

  • 识别年龄<10岁、男性、致癌性融合基因及甲状腺外侵犯等侵袭性相关因素可能指导治疗与预后判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Differentiated thyroid carcinoma (DTC) is rare in children, comprising 2% to 4% of pediatric cancers. Because of low case volumes at individual institutions, comprehensive data on patient and tumor characteristics and treatment outcomes are limited. The Child and Adolescent Thyroid Consortium was established in 2019 to address this gap and to assess impact of changes in practice on outcomes. OBJECTIVE: This inaugural Child and Adolescent Thyroid Consortium study analyzes the landscape of pediatric DTC and predictors of invasive disease. DESIGN: International, multicenter retrospective analysis of children (<age 19 years) with DTC diagnosed from 2010 to 2019. SETTING: Five high-volume pediatric centers. RESULTS: The cohort included 715 children (78.3% female) diagnosed with DTC at median age 15.2 years (range: 3.2-18.9). There were 673 (94%) patients with papillary thyroid carcinoma (PTC) and 42 (6%) had follicular thyroid carcinoma. Among patients with PTC, stage 1(M0) disease was present in 562 individuals (83.5%; 222 N0, 161 N1a, and 179 N1b). Stage 2 (M1) disease was present in 111 (16.5%) children with PTC and 1/42 (2.4%) with follicular thyroid carcinoma. Males and children aged <10 years exhibited more advanced T, N, and M stages. Any extrathyroidal extension correlated with increased nodal and pulmonary metastases. Oncogenic fusions, compared with BRAFV600E, were associated with more advanced N and M stages. Deintensification of therapy since 2015 was not associated with changes in disease outcomes. CONCLUSION: Invasive DTC is associated with age <10 years, male sex, tumors driven by oncogenic fusions, and extrathyroidal extension. Despite less aggressive therapies in recent years, disease outcomes have not worsened. Recognition of these associations may guide care and prognostication.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Wasserman JD, Isaza AR, Waguespack SG, et al. The landscape of pediatric differentiated thyroid carcinoma and predictors of invasive disease: a CATC study. J Clin Endocrinol Metab. 2026. PMID: 42025318. doi:10.1210/clinem/dgag172

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。